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The duration of ERK pathway signalling determines the proliferative
response of cells. A recent study has shown that cell cycle re-entry
requires the downregulation of an anti-proliferative gene cluster
following sustained activation of the ERK pathway.Andrew D. Sharrocks
It is becoming increasingly clear
that cellular signalling pathways
are not simple ‘on-off’ switches but
that spatial and temporal effects
are important in determining the
outcomes and biological effects
of these pathways. This is
exemplified by the ERK MAP
kinase pathway where differential
biological outcomes can be elicited
depending on the duration of
activation of the pathway (reviewed
in [1,2]). Indeed, the ERK MAP
kinase cascade plays an important
role in controlling cellular
proliferation and differentiation,
and in certain cell types, such as
neuronally derived PC12 cells,
the decision between these two
endpoints is dependent on
sustained signalling (reviewed in
[1,3]). In fibroblasts, the induction
of cell cycle re-entry requires
sustained ERK signalling and
the subsequent activation of
successive waves of gene
expression, culminating in a set of
proliferative genes that includes
cyclin D1 [2,4–6]. This gene
activation process was considered
to be sufficient to send quiescent
cells back into the cell cycle.
However, a recent study from
Nishida and colleagues [7],
published recently in Current
Biology, has focused on the
response of fibroblasts to
sustained ERK signalling and has
revealed a novel molecular
mechanism underlying this
phenomenon. In addition to the
activation of gene expression, the
repression of a cohort of anti-
proliferative genes was found to be
a key determinant of how sustained
ERK signalling can permit
a proliferative response to growth
factor signalling [7].
In fibroblasts, different growth
factors generate different profiles
of ERK pathway activation. WhileFGF causes sustained ERK
pathway activation and promotes
proliferation, EGF is incapable of
generating sustained ERK pathway
activation and a proliferative
response in this cell type. The
progression of fibroblasts from
a quiescent to proliferative state is
characterised by the induction of
interdependent waves of gene
expression. The first of these
involves immediate early genes,
which are then directly responsible
for triggering the expression of the
delayed early genes [8–10]. One of
these delayed early genes encodes
cyclin D1, which plays a pivotal role
in enabling cells to re-enter the cell
cycle and progress into S phase.
Importantly, cyclin D1 expression
is not activated by transient ERK
signalling but is only triggered after
sustained activation of this
pathway [11–13]. AP-1 family
proteins play a major part in cyclin
D1 regulation at the transcriptional
level and one of these proteins,
c-Fos, is encoded by a key
immediate early gene activated by
the ERK pathway. However, while
both transient and sustained ERK
pathway signalling upregulate
c-fos transcription, only sustained
ERK signalling leads to
hyperphosphorylation of c-Fos
protein and its subsequent
stabilisation (Figure 1) [2,14,15].
This stabilisation then allows it to
activate the expression of the
delayed early genes, culminating in
cyclin D1 activation and S phase
entry. Thus, c-Fos can act as
a molecular sensor for the levels of
ERK pathway activation that can
ultimately promote entry into
S phase. The recent work from
Nishida and colleagues [7] has now
identified another important
molecular event that is at least in
part directly controlled by c-Fos
and other AP-1 components in
response to sustained ERK
signalling — the downregulation ofa key group of anti-proliferative
genes.
To address the mechanisms
responsible for the differential
proliferative response to the
duration of ERK pathway
signalling, Nishida and colleagues
turned to NIH3T3 fibroblasts [7].
In this model system, FGF gives
an initial transient burst of ERK
pathway activation followed
by sustained activation and
a proliferative response, whereas
other growth factors, such as
PDGF and EGF, only induce
transient activation of this pathway
and are non-mitogenic. Using
microarray analysis, a cluster of
genes were identified which are
downregulated in response to FGF
signalling in an ERK-dependent
manner. This cohort of genes was
only downregulated under
conditions of sustained ERK
signalling. A number of these genes
encode transcription factors, such
as JunD, Sox6 and MEF2C,
suggesting that these
transcriptional regulators may be
important in determining
downstream responses to
sustained signalling. Indeed, many
of these have previously been
shown to be anti-proliferative and
the authors demonstrate that
overexpression of these factors
reduces the proliferative capacity
of fibroblasts. Other genes that
were downregulated under these
conditions also exhibit similar
anti-proliferative properties. For
example, RNAi-mediated depletion
of Gadd45a, Cpeb4 and Tob1
increases the proliferative capacity
of cells. Importantly, therefore,
a cohort of genes has been
identified that has anti-proliferative
capacity and must be
downregulated to permit cell cycle
re-entry. As the expression of these
genes is only affected following
sustained MAP kinase signalling,
these genes may act as a fail-safe
mechanism to prevent accidental
triggering of cell cycle re-entry by
inappropriate signals that only
generate a transient response.
What then is the link between
immediate early gene products
and the regulation of this group
of anti-proliferative genes? While
not extensive, clear links are
established between a requirement
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downregulation of this cohort of
genes. Dominant-negative c-Fos
constructs interfere with the
downregulation of the majority of
anti-proliferative genes,
demonstrating c-Fos’s
involvement in this event. Indeed,
some of the genes such as JunD
appear to be direct targets of
c-Fos, as revealed by chromatin
immunoprecipitation analysis,
whereas others are only indirectly
affected (e.g. Gadd45a). Thus,
a link to previous studies
implicating c-Fos as a key sensor
of ERK pathway signalling duration
is provided [2,14,15]. c-Fos can
therefore lead either to
downregulation of the anti-
proliferative gene cluster or to
upregulation of other genes, such
as cyclin D1, that are important for
promoting proliferation. How c-Fos
causes both activation and
repression is unclear, but one
possible mechanism through
which it might act in an indirect
manner would be through the
upregulation of a transcriptional
repressor protein (Figure 1B).
Together with previous studies,
a more comprehensive model
can now be proposed for how
sustained MAP kinase signalling
can lead to cell-cycle re-entry in
fibroblasts (Figure 1), involving the
triggering of secondary gene
expression programmes (the
delayed early genes) through both
repressive and activating activities.
Both of these activities are
promoted by c-Fos which is itself
the molecular sensor for detecting
sustained ERK signalling activity.
Importantly, this new model might
shed light on some outstanding
questions and have an impact on
our ability to control cancer. In
contrast to the situation in
fibroblasts, transient ERK
signalling in neuronally derived
PC12 cells leads to proliferation,
whereas sustained signalling leads
to differentiation of these cells
(reviewed in [1,2]). Thus, this clear
difference from the situation in
fibroblasts illustrates that there are
cell-type-specific mechanisms that
interpret the signalling status of the
ERK pathway and translate it into
a distinct cellular response. Why,
therefore, is a proliferative
response not elicited in PC12 cellsA
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Figure 1. Gene regulatory
events controlling cell cycle
re-entry.
(A) Transcriptional events
following transient ERK
pathway activation. ERK ac-
tivity shows a rapid peak
and return to basal levels.
This triggers the activation
of immediate early genes,
such asc-fos, through phos-
phorylation of transcription
factors like Elk-1. c-Fos pro-
tein is then produced and
degraded. (B) Transcrip-
tional events following sus-
tained ERK pathway activa-
tion. ERK activity shows a
rapid peak but then is main-
tained at a lower level. This
triggers the same immediate
early response, but c-Fos
protein is protected from
degradation through subse-
quent ERK-mediated phos-
phorylation. c-Fos can then
initiate a second wave
of transcriptional regulation
where a cohort of anti-
proliferative genes are re-
pressed either directly (e.g.
JunD, i) or indirectly through
the induction of a repressor
(Rep; e.g. Gadd45a, ii). In
addition, c-Fos also leads
to the activation of a set of
genes required for prolifera-
tion (e.g. CycD1, iii). Collec-
tively, this transcriptional
response permits cell cycle
entry.following sustained ERK signalling
but instead in response to transient
signalling? This latter observation
might be explained if the
anti-proliferative gene cluster is
maintained at a low level in PC12
cells compared with fibroblasts,
negating the need to downregulate
this cluster and permitting cell
cycle re-entry in response to
transient signalling. Sustained
signalling could instead activate
an alternative cohort of genes
required for differentiation. Finally,
another important implication of
the study relates to cancer cells
that often have high basal levels ofERK pathway activity, caused
through either overexpression or
oncogenic mutation of pathway
components such as Ras or B-Raf
(reviewed in [3]). It would be
interesting to determine the status
of the anti-proliferative gene
cluster identified by Nishida and
colleagues [7] across a number
of these cancers. Through
selective re-activation of the
anti-proliferative genes, it
might be possible to block
ERK-pathway-mediated
oncogenic events and hence
provide an effective therapeutic
strategy. Thus, in addition to
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R542providing a more comprehensive
understanding of how cell cycle
re-entry is achieved, the recent
findings point to potentially
exciting new avenues to pursue
in the drive to combat cancer.
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parental genome dosage. This has
been proposed to result from
a requirement for balanced
expression levels of a limited
number of imprinted genes —
genes expressed only from either
the maternal or paternal allele —
rather than the entire genome [4].
Consistent with this, proper
endosperm development depends
critically on several genes known to
be imprinted. Disruption of these
genes results in endosperm
defects similar to those observed in
interploidy crosses, suggesting
a causal relationship [5,6].
Major genome-wide changes
in gene silencing and DNA
methylation patterns often occur
in interploidy crosses in plants [7].
Nevertheless, in at least some
cases, aberrations observed in
interploidy crosses seem to be
attributable to genic interactions.
Josefsson et al. [1] found that
misregulation of an imprinted gene
PHERES1 (PHE1) is specific to the
hybrid context, and not caused by
ploidy differences per se. PHE1
over-expression was observed in
A. thaliana x A. arenosa hybrid
seeds, but not in A. thaliana
interploidy crosses [1]. This
parallels another recent study [8],
